Nutritional changes in patients with locally advanced head and neck cancer during treatment

被引:52
|
作者
Arribas, L. [1 ,2 ,3 ,4 ]
Hurtos, L. [1 ,2 ]
Taberna, M. [2 ,3 ,4 ,5 ,6 ]
Peiro, I. [1 ,2 ]
Vilajosana, E. [3 ]
Lozano, A. [2 ,3 ,7 ]
Vazquez, S. [2 ,3 ,5 ]
Mesia, R. [2 ,3 ,4 ,8 ]
Virgili, N. [2 ,4 ,9 ]
机构
[1] Catalan Inst Oncol ICO, Clin Nutr Unit, Barcelona, Spain
[2] Bellvitge Biomed Res Inst IDIBELL, Barcelona, Spain
[3] Bellvitge Univ Hosp, Catalan Inst Oncol ICO, Head & Neck Canc Unit, Barcelona, Spain
[4] Univ Barcelona, Barcelona, Spain
[5] Catalan Inst Oncol ICO, Med Oncol Dept, Barcelona, Spain
[6] Catalan Inst Oncol ICO, Canc Epidemiol Res Program, Barcelona, Spain
[7] Catalan Inst Oncol ICO, Radiat Oncol Dept, Barcelona, Spain
[8] Catalan Inst Oncol ICO, Med Oncol Dept, Barcelona, Spain
[9] Bellvitge Univ Hosp, Nutr & Endocrinol Dept, Nutr & Dietet Unit, Barcelona, Spain
关键词
Clinical Oncology treatment; Head and neck cancer; Nutrition; Dietary counseling; Fat free mass; SQUAMOUS-CELL CARCINOMA; BIOELECTRICAL-IMPEDANCE ANALYSIS; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; ASSESSMENT PG-SGA; BODY-COMPOSITION; CHEMOTHERAPY; CHEMORADIOTHERAPY; CETUXIMAB; CACHEXIA; THERAPY;
D O I
10.1016/j.oraloncology.2017.06.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: The purpose of the study is to evaluate changes in body composition and nutritional status that occur throughout the oncological treatment in head and neck cancer patients. Methods: A prospective cohort observational study in patients diagnosed with head and neck squamous cell carcinoma (HNSCC) that underwent treatment with induction chemotherapy (iCT) followed by chemoradiotherapy or bioradiotherapy were invited to participate. All patients had dietetic counseling from the diagnosis and a close monitoring throughout the treatment implementing nutritional support as needed. Results: From June 2011 until October 2012, 20 patients were included. Nutritional and anthropometric parameters were collected at diagnosis, post iCT, after radiotherapy, 1 and 3 months post radiotherapy. According to Patient Generated Subjective Global Assessment, 30% of patients were malnourished at diagnosis. After iCT there was an increase in weight, body mass index (BMI) and fat free mass (FFM) with almost complete improvement in dysphagia and odynophagia. Nevertheless a significant nutritional deterioration (p = 0.0022) occurred at the end of radiotherapy with 95% of patients becoming severe or moderate malnourished. Nutritional parameters such as weight, BMI and hand grip strength also decrease significantly during treatment. Conclusions: Despite an intensive nutritional support from the diagnosis throughout the oncological treatment in advanced HNSCC cancer patients, nutritional status deteriorates during radiotherapy. Our findings suggest that iCT may help improve nutritional status by ameliorating the symptoms that limit the oral intake. This improvement in the nutritional status could contribute to minimize further deterioration. Further investigations are needed involving novel approaches to avoid nutritional deterioration. (C) 2017 Elsevier Ltd. All rights reserved.
引用
收藏
页码:67 / 74
页数:8
相关论文
共 50 条
  • [21] Nutritional Interventions in Head and Neck Cancer Patients Undergoing Chemoradiotherapy: A Narrative Review
    Bossola, Maurizio
    NUTRIENTS, 2015, 7 (01) : 265 - 276
  • [22] Severe Radiation Dermatitis in Patients With Locally Advanced Head and Neck Cancer Treated With Concurrent Radiation and Cetuximab
    Koutcher, Lawrence D.
    Wolden, Suzanne
    Lee, Nancy
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2009, 32 (05): : 472 - 476
  • [23] Nutritional Issues in Head and Neck Cancer Patients
    Bozzetti, Federico
    Cotogni, Paolo
    HEALTHCARE, 2020, 8 (02)
  • [24] Nutritional management of patients with head and neck cancer treated with radiation
    Thureau, S.
    Lefebvre, L.
    Dandoy, S.
    Guerault, F.
    Ebran, M.
    Lebreton, M.
    Veresezan, O.
    Rigal, O.
    Clatot, F.
    CANCER RADIOTHERAPIE, 2015, 19 (6-7): : 552 - 555
  • [25] Neoadjuvant TPF in locally advanced head and neck cancer can be followed by radiotherapy combined with cisplatin or cetuximab: a study of 157 patients
    Fayette, Jerome
    Bonnin, Nathalie
    Ferlay, Celine
    Lallemant, Benjamin
    Ramade, Antoine
    Favrel, Veronique
    Zrounba, Philippe
    Chabaud, Sylvie
    Pommier, Pascal
    Poupart, Marc
    Ceruse, Philippe
    ANTI-CANCER DRUGS, 2013, 24 (06) : 623 - 629
  • [26] Management of Older Adults with Locally Advanced Head and Neck Cancer
    Dickstein, Daniel R.
    Lehrer, Eric J.
    Hsieh, Kristin
    Hotca, Alexandra
    Jones, Brianna M.
    Powers, Ann
    Sharma, Sonam
    Liu, Jerry
    Gupta, Vishal
    Mell, Loren
    Husain, Zain
    Kirke, Diana
    Misiukiewicz, Krzysztof
    Posner, Marshall
    Genden, Eric
    Bakst, Richard L.
    CANCERS, 2022, 14 (11)
  • [27] EGFR Status and Prognosis of Patients with Locally Advanced Head and Neck Cancer Treated with Chemoradiotherapy
    Numico, Gianmauro
    Russi, Elvio Grazioso
    Colantonio, Ida
    Lantermo, Rosa Anna
    Silvestris, Nicola
    Vitiello, Raffaele
    Comino, Alberto
    Abrate, Mario
    Zavattero, Carla
    Melano, Antonella
    Merlano, Marco
    ANTICANCER RESEARCH, 2010, 30 (02) : 671 - 676
  • [28] Changes in Nutrition Impact Symptoms, Nutritional and Functional Status during Head and Neck Cancer Treatment
    Neoh, May Kay
    Abu Zaid, Zalina
    Daud, Zulfitri Azuan Mat
    Yusop, Nor Baizura Md
    Ibrahim, Zuriati
    Rahman, Zuwariah Abdul
    Jamhuri, Norshariza
    NUTRIENTS, 2020, 12 (05)
  • [29] Chemo-immunotherapy and radiation in locally advanced head and neck cancer: Where do we stand?
    Belgioia, L.
    Becherini, C.
    Bacigalupo, A.
    Bonomo, P.
    ORAL ONCOLOGY, 2022, 127
  • [30] Indications for chemoradiotherapy in older patients with locally advanced head and neck cancer in Japan: a questionnaire survey in the JCOG head and neck cancer study group
    Yasuda, Koichi
    Kiyota, Naomi
    Matsuura, Kazuto
    Saito, Satoshi
    Honma, Yoshitaka
    Imamura, Yoshinori
    Tanaka, Kaoru
    Zenda, Sadamoto
    Onoe, Takuma
    Kodaira, Takeshi
    Kobayashi, Satoshi
    Aoyama, Hidefumi
    Hanai, Nobuhiro
    Homma, Akihiro
    Head Neck Canc Study Grp
    Japan Clin Oncology Grp JCOG
    FRONTIERS IN ONCOLOGY, 2025, 14